glp 1 agonist action Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Glucagon-like peptide-1 receptor: mechanisms and

Description

The risk to benefit profile of these agents and outcomes data are key as we evaluate the evidence

Weight loss goals should be personalized to each patient and weighed against risks of contributing to sarcopenia

Next Steps At TMH, we have a robust, multidisciplinary team to help you through your weight loss journey

The AMPLITUDE-O trial, which included more high-risk patients and had a higher prevalence of kidney disease than the previous GLP-1RA CVOT trials, observed an overall lower incidence of at least one MACE composite event

Although infrequent, severe complications such as pancreatitis and gallbladder disease along with thyroid C-cell hyperplasia have been observed, and rodent research indicates a potential risk for developing medullary thyroid carcinoma [10]